Pexa Establishes Control Balance Sheet Amid Financial Concerns

Pexa, a company engaged in medical research, has announced the establishment of a control balance sheet due to significant concerns regarding its financial health. The board made this decision public on August 26, 2025, stating that it comes after indications that the company may have depleted half of its share capital, a crucial warning sign of its financial distress.

The creation of a control balance sheet is a noteworthy action, asserting the need for increased scrutiny over the company's finances. This measure underscores Pexa's current financial challenges and signifies a pressing need for the company to address potential solvency issues.

The announcement was made at 16:32 local time, further emphasizing the urgency with which Pexa is approaching its precarious financial situation. Stakeholders and investors will likely be watching closely as the company navigates this troubled period and attempts to restore stability and confidence among its investors and the broader market.